Home | Articles
Published on:September 2022
Indian Journal of Pharmaceutical Education and Research, 2022; 56(4):1044-1051
Original Article | doi:10.5530/ijper.56.4.185

Formulation Development and Optimization of Famotidine Mucoadhesive Tablets by Central Composite Design


Authors and affiliation (s):

Haranath Chinthaginjala1,*, Mousami Bhavasar Telkar1, Abdul Ahad Hindustan2, Pradeepkumar Bhupalam3

1Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research, Chiyyedu, Andhra Pradesh, INDIA.

2Department of Industrial Pharmacy, Raghavendra Institute of Pharmaceutical Education and Research, INDIA.

3Department of Pharmacology, Raghavendra Institute of Pharmaceutical Education and Research, INDIA.

Abstract:

Objectives: The intention of present study is to formulate and optimize the famotidine mucoadhesive tablets y using Central Composite Design. Materials and Methods: The concentrations of Cordia dichotoma fruit mucilage powder (X1) and Polyvinyl pyrrolidone (X2) were demonstrated as independent variables. Whereas, the dependent variables were selected such as an in vitro Mucoadhesion Time and percentage Drug Release. The model was considered to be nonlinear and the curvature effect was significant. Hence, the study reported to Central Composite Design. By using wet granulation method, the tablets were prepared and all the formulated tablets were evaluated for its post compression parameters. Results: The drug and the excipients had no interaction, according to FT-IR and DSC analyses. All formulations showed Mucoadhesion Time ranging from 5 hr to 9 hr and % Drug Release in the range of 96.4% to 99.69%. The association amongst the dependent variable and independent variables was judge by using Contour plots. Conclusion: The outcomes indicated the efficacy of the proposed design for famotidine Mucoadhesive tablets development.

Keywords: Optimization, Central Composite Design, Drug Release, Famotidine, Muco adhesive.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).

 

Impact Factor® as reported in the 2023 Journal Citation Reports® (Clarivate Analytics, 2023): 0.8

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs